Serum alanine transaminase is predictive of fasting and postprandial insulin and glucagon concentrations in type 2 diabetes

The ‘early’ postprandial glucagon response is related to the rate of gastric emptying in type 2 diabetes

(2023) Weikun Huang et al.   PEPTIDES

Measurement of plasma glucagon in humans ‐ a shift in the performance of a current commercially available RIA kit

(2022) Tongzhi Wu et al.   DIABETES OBESITY & METABOLISM

ALT/AST as an Independent Risk Factor of Gestational Diabetes Mellitus Compared with TG/HDL-C

(2022) Shuoning Song et al.   International Journal of General Medicine

The Liver-Alpha Cell Axis in Health and in Disease

(2022) Michael M. Richter et al.   DIABETES

Mechanisms controlling pancreatic islet cell function in insulin secretion

(2021) Jonathan E. Campbell et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial

(2020) Christopher K. Rayner et al.   DIABETES CARE

Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycemia in health and type 2 diabetes

(2019) Karen L. Jones et al.   DIABETES OBESITY & METABOLISM

Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes

(2018) Nicolai J. Wewer Albrechtsen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids

(2018) Nicolai J. Wewer Albrechtsen et al.   DIABETOLOGIA

A whey/guar “preload” improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12-week, single-blind, randomized, placebo-controlled trial

(2018) Linda E. Watson et al.   DIABETES OBESITY & METABOLISM

Liver glucose metabolism in humans

(2016) M. M. Adeva-Andany et al.   BIOSCIENCE REPORTS

A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes

(2016) Tongzhi Wu et al.   DIABETES CARE

Non-alcoholic fatty liver disease and diabetes

(2016) Jonathan M. Hazlehurst et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease

(2014) Maryann Maximos et al.   HEPATOLOGY

Physiological and Biochemical Basis of Clinical Liver Function Tests

(2012) Lisette T. Hoekstra et al.   ANNALS OF SURGERY

Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes

(2012) K.-C. Sung et al.   DIABETES CARE

Liver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and Women

(2011) F. Bonnet et al.   DIABETES

The role of dysregulated glucagon secretion in type 2 diabetes

(2011) D. D'Alessio   DIABETES OBESITY & METABOLISM

Physiologic action of glucagon on liver glucose metabolism

(2011) C. J. Ramnanan et al.   DIABETES OBESITY & METABOLISM

One-hour post-load plasma glucose levels are associated with elevated liver enzymes

(2011) E. Succurro et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Alanine Aminotransferase,  -Glutamyltransferase, and Incident Diabetes: The British Women's Heart and Health Study and meta-analysis

(2009) A. Fraser et al.   DIABETES CARE